Prairie Vascular Research Inc.   Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2014
NCT01930591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now